Over the last two decades, many studies in rodents and humans revealed the association of elevated endostatin levels with several diseases, e.g. gastric cancer [21], diabetes mellitus [9], atherosclerosis [22], Alzheimer’s disease [23] and chronic kidney disease (CKD) [24]. This evidence concerns the gene COL18A1 and early-onset autosomal dominant Alzheimer disease.